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Long non-coding RNAs (lncRNAs) regulate diverse
biological processes, including cell lineage specifi-
cation. Here, we report transcriptome profiling of
human endoderm and pancreatic cell lineages using
purified cell populations. Analysis of the data sets
allows us to identify hundreds of lncRNAs that
exhibit differentiation-stage-specific expression pat-
terns. As a first step in characterizing these lncRNAs,
we focus on an endoderm-specific lncRNA, defini-
tive endoderm-associated lncRNA1 (DEANR1), and
demonstrate that it plays an important role in
human endoderm differentiation. DEANR1 contrib-
utes to endoderm differentiation by positively regu-
lating expression of the endoderm factor FOXA2.
Importantly, overexpression of FOXA2 is able to
rescue endoderm differentiation defects caused
by DEANR1 depletion. Mechanistically, DEANR1
facilitates FOXA2 activation by facilitating SMAD2/3
recruitment to the FOXA2 promoter. Thus, our
study not only reveals a large set of differentiation-
stage-specific lncRNAs but also characterizes a
functional lncRNA that is important for endoderm
differentiation.INTRODUCTION
Definitive endoderm (DE) specification is one of the first critical
steps in early development that generate gastrointestinal tracts
and all of the associated organs/tissues, including the pancreas
and liver (Zorn and Wells, 2009). Previous studies have shown
that human embryonic stem cells (ESCs) and induced pluripo-
tent stem cells (iPSCs) could be induced to differentiate into
DE and further into pancreatic progenitors (PPs), as well as
islet-like structures exhibiting a partial insulin-secretion function
(D’Amour et al., 2006; Jiang et al., 2007; Nostro et al., 2011;
Zhang et al., 2009). The derived PPs can be further matured toform well-structured islets that are capable of responding to
glucose following transplantation in mouse models (Kroon
et al., 2008). However, the in vivo maturation approach was
not applicable to clinical studies or suitable for generating large
quantities of relevant cells for drug screening until very recently,
when two groups reported their success in making functional
beta cells in vitro (Pagliuca et al., 2014; Rezania et al., 2014).
Additionally, differences between human and mouse endoderm
and beta cell development, such as cell-cell interaction and islet
structure, have prevented direct translation of the knowledge
gained from mouse studies to human applications (McKnight
et al., 2010). For instance, a microarray-based transcriptome
analysis of human exocrine and endocrine pancreatic cell types
not only revealed enrichment of genes important for paracrine
signaling but also showed an unexpected abundance of some
regulatory proteins, including MAFB in beta cells, distinct from
those reported in mouse (Dorrell et al., 2011). Since the study
of human development is hampered by limited access to human
tissues, particularly of the embryonic stage, understanding
cell-lineage-specific differentiation of human ESCs provides an
alternative. Indeed, a recent study utilized such a system to
investigate human cardiac lineage specification (Paige et al.,
2012). Therefore, it is possible that a comprehensive transcrip-
tome characterization of the different developmental stages of
endoderm and pancreatic cell lineages would generate a rich
resource for understanding the regulatory networks of cell line-
age specification and provide additional insights into the mech-
anism of beta cell differentiation.
The FANTOM and ENCODE projects have revealed that a
large proportion of the mammalian genome is transcribed (Car-
ninci et al., 2005; Djebali et al., 2012; Katayama et al., 2005).
Thousands of these transcripts are classified as long non-coding
RNAs (lncRNAs), with size larger than 200 nucleotides, but very
few have been functionally characterized. Biochemically,
lncRNAs have been shown to mediate local gene expression in
cis, affect multiple gene transcription in trans, and serve as a
scaffold for chromatin structure maintenance (Rinn and Chang,
2012; Ulitsky and Bartel, 2013). Functionally, lncRNAs have
been shown to regulate diverse biological processes, including
X chromosome inactivation, genomic imprinting, cell-cycle regu-
lation, and regulation of stem cell pluripotency (Wang andCell Reports 11, 137–148, April 7, 2015 ª2015 The Authors 137
Chang, 2011). Moreover, lncRNAs are less conserved compared
with protein coding genes of different species and exhibit tissue-
and cell-type-specific expression (Cabili et al., 2011; Derrien
et al., 2012). Very recently, Fendrr, an lncRNA that is specifically
expressed in lateral mesoderm, was shown to be important for
mouse heart and bodywall development (Grote et al., 2013; Sau-
vageau et al., 2013); Braveheart, a mouse- and heart-specific
lncRNA, was shown to be required for nascent mesoderm to
cardiac fate specification (Klattenhoff et al., 2013); TINCR, a ter-
minal differentiation-induced lncRNA in human epidermis, was
reported to control epidermal differentiation (Kretz et al., 2013);
and lnc-DC, an lncRNA that is exclusively expressed in human
dendritic cells, was shown to regulate dendritic cell differentia-
tion (Wang et al., 2014). Collectively, these reports support the
significance of lncRNAs in cell lineage specification and embry-
onic development.
Endoderm specification is controlled by a number of signaling
pathways and transcriptional factors (Zorn and Wells, 2009), but
whether lncRNAs play any role in this process is largely
unknown. Interestingly, a recent study reported that during
ESC-to-endoderm differentiation, more than 60% of expressed
lncRNAs exhibit coordinated expression changes with their
associated protein-coding genes (Sigova et al., 2013). Given
that lncRNAs are capable of contributing to the regulation of
gene expression, they may have a role in endoderm and pancre-
atic cell lineage specification, which has yet to be defined.
Here, we profiled the transcriptome and revealed the dynamic
expression pattern of many lncRNAs during endoderm and
pancreatic cell lineage specification. We further characterized
the function and mechanism of action for an important endo-
derm-specific lncRNA that we named definitive endoderm-asso-
ciated lncRNA1 (DEANR1).
RESULTS
Preparation of Purified Cell Samples along the
Endoderm and Pancreatic Endocrine Cell Lineage
We previously reported a protocol by which PPs can be gener-
ated in vitro by differentiation of human ESCs through the DE
stage (Jiang et al., 2011; Zhang et al., 2009). Based on available
cell-surface markers of the desired cell types, we prepared puri-
fied cell samples along the beta cell lineage, including undiffer-
entiated human ESCs, DE, PPs, and primary adult islet-derived
alpha and beta cells. First, we utilized a well-known human
ESC surface marker (SSEA-4) combined with a lack-of-lineage
marker (CD184) to purify undifferentiated human ESCs (Fig-
ure 1A). Since CD184 and CD117 can serve as surface markers
for DE (Cheng et al., 2012; Nostro et al., 2011), we sorted CD184/
CD117 double-positive cells (as putative DE cells) after subject-
ing human ESCs toDE differentiation (Jiang et al., 2013a, 2013b).
We also combined CD24 (Jiang et al., 2011) with CD49f markers
(Figure 1B) and purified theCD24high/CD49fmed population as the
putative PP cells (Figure 1A). Fluorescence-activated cell sorting
(FACS; Figure 1B) and qRT-PCR (Figure 1C) analysis confirmed
the cell identities as expected.
Since no cell-surface marker for human ESC-derived beta-like
cells has been reported, we chose to purify beta cells from pri-
mary human islets based on the antibodies developed by Dorrell138 Cell Reports 11, 137–148, April 7, 2015 ª2015 The Authorset al. (2008, 2011). From multiple primary human islet prepara-
tions, we purified beta cells (HPi2+/HPa1) and alpha cells
(HPi2+/HPa1+) (Figure 1D). qRT-PCR analysis of cell-type-spe-
cific factors demonstrated that the cell purification was success-
ful (Figure 1E; Insulin and MAFA mark beta cells, and Glucagon
and ARX mark alpha cells).
Expression Dynamics of Protein-Coding Genes during
Endoderm and Pancreatic Cell Lineage Specification
To characterize the transcriptional changes that occur during
pancreatic beta cell differentiation, we performed RNA seq-
uencing (RNA-seq) using FACS-sorted cells from 11 samples
(ES, n = 2; DE, n = 2; PP, n = 3; alpha, n = 2; beta, n = 2) and a
modified SMARTseq procedure for Illumina library construction
(Yamaguchi et al., 2012) (detailed in Experimental Procedures).
For each sample, we generated 24–45 million raw reads,
>80% of which mapped uniquely (Figure S1A). Approximately
15,416 human genes were detected under the criteria of FPKM
>1 in replicates. Cluster analysis indicated that the data are high-
ly reproducible (Figure 2A). Inspection of well-known stage-spe-
cific markers, such as SOX2, SOX17, SOX9, PDX1, insulin, and
glucagon, confirmed their expected stage-specific expression
(Figure S1B). The stage-specific expressed genes were enriched
for Gene Ontology terms that are consistent with the function of
the cells (Figure 2B). Collectively, these results are consistent
with human endoderm and pancreatic cell lineage specification
and development, and confirm the reliability of the data sets.
To examine the transcriptome changes that occur between
developmentally related stages, we performed a pairwise com-
parison. Using stringent criteria (log2 [fold change] > 1.5, p
value < 0.05 and higher FPKM > 5), we identified hundreds of
differentially expressed genes in each comparison. KEGG signal
pathway enrichment analysis (Huang et al., 2009) revealed that
cell-cycle and related pathways, including metabolism and
cancer pathways, were enriched in most differentiation stages
(Figure 2C), which is consistent with the observation that the pro-
liferation capacity becomes restricted during cell-fate specifica-
tion. As expected, several pathways that were previously
demonstrated to be involved in pancreatic cell differentiation
were enriched in the pairwise analysis. For example, genes of
the TGFbeta signaling pathway were enriched in both the human
ES-to-DE and DE-to-PP transitions. Interestingly, MAPK and
focal adhesion pathways were exclusively enriched in the PP-
to-alpha transition, while the ErbB signaling pathway was exclu-
sively enriched in the PP-to-beta transition (Figure 2C). These
results suggest that these signaling pathways might coordinate
PP-to-alpha/beta cell differentiation. Although previous studies
of mice and other vertebrates have reported that multiple
signaling pathways are involved in endoderm and pancreatic
specification (Zorn and Wells, 2009), these pairwise compari-
sons may provide valuable information for optimizing in vitro hu-
man pancreatic differentiation procedures.
lncRNA Expression during Endoderm and Pancreatic
Lineage Specification Is Highly Stage Specific
To identify lncRNAs expressed during human endoderm and
pancreatic lineage specification, we mapped RNA-seq data
against the GENCODE v14 lncRNA annotation (Derrien et al.,
Figure 1. Purification of Samples for Transcriptome Analysis
(A) Purification of human ESCs, DE, and PPs. The top panel illustrates in vitro differentiation (R, retinoic acid; N, Noggin; K, KGF), immunostaining, and FACS
sorting of human ESCs (SSEA4+/CD184), DE (CD184+/CD117+), and PPs (CD24high/CD49fmed).
(B) Flow-cytometric analysis demonstrates that PDX1-positive cell populations are CD24high/CD49fmed.
(C) Comparison of the gene expression of key pancreatic transcriptional factors betweenCD24high/CD49fmed (Pos) and the remaining cells (Neg). Shown are three
independent experiments.
(D) Purification of alpha and beta cells from human primary islets using HPi2 and HPa1. HPi2+/HPa1 mark beta cells, and HPi2+/HPa1+ mark alpha cells.
(E) qRT-PCR analysis of cell-type-specific marker gene expression confirms the identity of sorted alpha, beta, and non-alpha/beta cells. Shown are three in-
dependent experiments.
See also Figure S1 and Table S4.2012) andHumanBodyMap intergenic lncRNA annotation (Cab-
ili et al., 2011). Using stringent criteria (FPKM > 1 in each repli-
cate), we identified 1,059 expressed intergenic lncRNAs that
were not located within any annotated protein-coding genes (Ta-
ble S1). Among these lncRNAs, 250 exhibit a stage-specific
expression pattern (Figure 3A), 62 are ES specific, 82 are DE spe-
cific, 28 are PP specific, 55 are beta specific, and 23 are alpha
specific. Representative stage-specific lncRNAs are shown inFigure 3C. Since lncRNAs likely co-express with their neigh-
boring genes (Cabili et al., 2011), we attempted to obtain some
insights into the functions of these lncRNAs by asking whether
the neighboring protein-coding genes of these lncRNAs (geno-
mic distance of <20 kb) are enriched for any biological pro-
cesses. A Gene Ontology term analysis revealed that protein-
coding genes close to the ES-specific lncRNAs are enriched
for regulation of cell division and transcription, and genes closeCell Reports 11, 137–148, April 7, 2015 ª2015 The Authors 139
Figure 2. Expression Analysis of Protein-
Coding Genes across Human Endoderm
and Pancreatic Cell Lineages
(A) Cluster analysis of the transcriptome across
human pancreatic cell lineages.
(B) Top enriched Gene Ontology terms of each
group of stage-specific expressed genes are
shown with gene counts and Fisher’s exact test
p value.
(C) Heatmap illustration of enriched KEGG
signaling pathways based on pairwise compari-
sons of the various developmental stages (Fisher’s
exact test, p value < 0.01). Color scale represents
the respective p value.to DE-specific lncRNAs are enriched for endoderm develop-
ment, dorsal/ventral pattern formation, and gastrulation (Fig-
ure 3B), suggesting a potential role for these lncRNAs in cell-fate
determination.
Previous studies have shown that lncRNAs are highly tissue
specific (Cabili et al., 2011; Mora´n et al., 2012). An analysis of
the lncRNA expression profiles during endoderm and pancreatic
lineage specification indicated that lncRNA expression is highly
stage specific: more than 25% of lncRNAs in most of the stages
exhibited a stage-specific expression pattern (13.9% for the PP
stage), whereas less than 5% of the protein-coding genes were
stage specific (Figure 3D). Consistent with previous reports
(Cabili et al., 2011; Mora´n et al., 2012), statistically significant
enrichment (p < 1 3 1016 for each comparison, chi-square
test) of lncRNAs over protein-coding genes was observed during
human endoderm and pancreatic lineage specification. To
investigate the potential role of these lncRNAs in differentiation,
we examined the relationship between the expression of these
lncRNAs and their neighboring protein-coding genes during
endoderm and pancreatic lineage specification. The expression
of lncRNAs and their neighboring genes was highly correlated in
ESCs, DE, and PP (Figure 3E); however, the correlation between
the expression of lncRNAs and their neighboring genes in
terminally differentiated islet cells was less robust when
compared with that of ES, DE, and PP samples (Figure 3E; p =
8.3 3 1015 compared with ESCs, p = 2.9 3 1016 compared
with DE, p = 4.2 3 108 compared with PP cells; Wilcoxon
rank sum test). These results suggest that lncRNAs in terminally
differentiated cells are less likely to be co-regulated by their
neighboring genes, indicating that they may serve specific func-
tions in terminally differentiated islet cells.
DEANR1 Is a Human-DE-Specific lncRNA
lncRNAs have been reported to participate in many biological
processes (Wang and Chang, 2011), but no lncRNA has been140 Cell Reports 11, 137–148, April 7, 2015 ª2015 The Authorsshown to be functionally important for
human endoderm and pancreatic line-
age specification. To begin to functionally
characterize the hundreds of lncRNAs
that exhibit stage-specific expression
during endoderm and pancreatic lineage
specification, we utilized a well-estab-
lished DE differentiation system to testwhether some of these lncRNAs have a role in DE differentiation.
To this end, we applied more stringent criteria (higher FPKM > 5,
log2 [fold change] > 1.5, p value < 0.05), and identified 38
lncRNAs that are differentially expressed in ESCs and DE cells
(13 highly expressed in ESCs and 25 highly expressed in DE
cells; Figure 4A; detailed information is provided in Table S2).
Among the 25 DE-expressed lncRNAs, 12 are located physically
close to protein-coding genes, including the endoderm factors
GATA6 and FOXA2. Given that GATA6-associated lncRNAs
are divergently transcribed, they likely share a promoter and
thus may confound analysis. Therefore, we decided to focus
on the FOXA2-associated lncRNA LINC00261. Because this is
the first DE-specific lncRNA to be characterized, we renamed
LINC00261 as DEANR1 (for definitive endoderm-associated
long non-coding RNA1).
Our RNA-seq data indicated that DEANR1 is highly expressed
in DE, albeit to a lower level than FOXA2 (FPKM: 10 versus 35;
Figure 4B). To further characterize the expression pattern of
DEANR1, we analyzed its expression level in human ESCs,
differentiated neuroectoderm (NE), differentiated embryoid
body (EB), and DE cells by qRT-PCR. The results presented in
Figure 4C indicate that the expression level of DEANR1 in DE
is at least 100-fold higher than in any of the other cell types
analyzed. Furthermore, a time-course analysis demonstrated
that the expression level of DEANR1 during endoderm differen-
tiation is gradually increased over differentiation (Figure 4D).
Based on these results, we conclude that DEANR1 is an lncRNA
that is highly expressed in human DE.
DEANR1 Is Important for Endoderm Differentiation but
Is Not Required for ESC Maintenance
To examine whether DEANR1 is functionally important for endo-
derm differentiation, we generated two small hairpin RNA
(shRNA) constructs targeting different regions of DEANR1. A
qRT-PCR analysis demonstrated that both shRNAs achieved
Figure 3. Dynamic Regulation of lncRNAs
during Human Endoderm and Pancreatic
Cell Lineage Specification
(A) Hierarchical clustering of 250 stage-specific
lncRNAs during human pancreatic cell lineage
specification. Red and blue represent high and low
expression, respectively.
(B) Top enriched Gene Ontology terms for stage-
specific lncRNA neighboring protein-coding genes.
(C) RNA-seq reads alignment of representative
stage-specific expressed lncRNAs. For each
lncRNA, the vertical axis is scaled at the same
expression level for all samples. The lncRNA tran-
scripts are depicted as black bars, with an arrow
indicating the transcription direction.
(D) Relative percentage of stage-specific ex-
pressed lncRNAs (red bars) compared with protein-
coding genes (gray bars) in five different human
pancreatic cell lineage samples (p < 1 3 1016 for
each comparison, chi-square test).
(E) Endocrine islet-expressed lncRNAs show less
correlation with the expression of their nearby
genes compared with the lncRNAs in ES (black),
DE (blue), and PP (purple) (p = 8.3 3 1015
compared to ES, p = 2.9 3 1016 compared with
DE, p = 4.23 108 compared to PP cells; Wilcoxon
rank sum test).
See also Table S1.70%–75% knockdown of DEANR1 in human ESCs (Figure S2A).
Importantly, neither knockdown affected human ESC mainte-
nance, as the expression level of pluripotent factors such as
SOX2, NANOG, and OCT4 was not altered in the stable knock-
down cell lines (Figures S2B and S2C). In addition, neither the
morphology nor the growth rate of the stable DEANR1 knock-
down cell lines was altered (data not shown). Thus, DEANR1
does not seem to be required for human ESC maintenance,
which is consistent with its low expression level in undifferenti-
ated ESCs (Figures 4B and 4C).
To evaluate the effect of DEANR1 knockdown on DE differen-
tiation, we subjected stable DEANR1 knockdown cell lines to
endoderm differentiation conditions. A FACS analysis revealed
that DEANR1 knockdown resulted in a decrease in the percent-
age of CD184/CD117 double-positive cells compared with the
control human ESCs (Figure 4E). Consistently, immunostainingCell Reports 11, 137results revealed that DEANR1 knockdown
cells exhibited a decreased expression of
endoderm marker genes, such as FOXA2
and SOX17, after being subjected to
endoderm differentiation (Figure 4F).
To further analyze the role of DEANR1 in
endoderm differentiation, we performed
RNA-seq of DEANR1-knockdown cells
after subjecting them to endoderm differ-
entiation (Table S3). Compared with differ-
entiated control cells, 632 genes were
downregulated and 569 genes were upre-
gulated (Figure 4G) upon DEANR1 knock-
down (FDR < 0.001 and fold change > 2).
These differentially expressed genes aresignificantly enriched for DE- and ES-signature genes. Among
these, 219 downregulated genes in DEANR1-knockdown cells
are DE-signature genes that are expected to be upregulated
during endoderm differentiation (Figure 4G, top). Thus, the
transcriptome analysis suggested a defective activation of endo-
derm genes in DEANR1-knockdown cells. A total of 194 upregu-
lated genes in DEANR1-knockdown cells are ES-signature
genes that should be downregulated during endoderm differen-
tiation (Figure 4G, bottom). These transcriptome data, together
with the differentiation data, suggest that DEANR1 plays an
important role in DE differentiation.
DEANR1 Regulates FOXA2 Expression
To identify potential targets of DEANR1 in endoderm differenti-
ation, we collected 47 RNA-seq data sets generated in
this study and others (Bramswig et al., 2013; Mora´n et al.,–148, April 7, 2015 ª2015 The Authors 141
Figure 4. Identification of DEANR1 as an Endoderm-Specific lncRNA
(A) Heatmap showing the expression levels of lncRNAs differentially expressed in ESCs and DE cells. Criteria: higher FPKM > 5, log2 (fold change) > 1.5, and p
value < 0.05. Red and blue represent high and low expression, respectively. See also Table S2.
(B) Relative enrichment of DEANR1 in DE compared with ESCs shown by FPKM. FOXA2 serves as a control.
(C) Relative expression level of DEANR1 in various cell types quantified by qRT-PCR. Undifferentiated ESCs (ES), differentiated neuroectoderm (NE), sponta-
neously differentiated embryoid body (EB), and DE samples were compared. The expression level in ES was set as one.
(D) The expression dynamics of DEANR1 during DE differentiation. The mean values are shown and error bars represent the SD from the mean (n = 3). The
expression level at day 0 was set as one.
(E) Representative FACS analysis showing a reduced CD117/CD184 double-positive DE cell population upon DEANR1 knockdown.
(F) Representative immunostaining of the DE markers SOX17 and FOXA2 in DE differentiated control and DEANR1 knockdown cells. Scale bar represents
100 mm.
(G) RNA-seq analysis of differentiated DEANR1-knockdown endoderm cells and control endoderm cells. Compared with control (FDR < 0.001 and fold change >
2), 632 genes were downregulated (significantly enriched in DE-signature genes) and 569 genes were upregulated upon DEANR1 knockdown (significantly
enriched in ES-signature genes). Among these, 219 downregulated genes in DEANR1-knockdown cells are DE-signature genes that should be upregulated
during endoderm differentiation (top), and 194 upregulated genes in DEANR1-knockdown cells are ES-signature genes that should be downregulated during
endoderm differentiation (bottom).
See also Figure S2 and Tables S3 and S4.
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Figure 5. FOXA2 Is a Major Functional
Target of DEANR1
(A) Genomic location and diagrammatic presenta-
tion of RNA-seq results in DE for DEANR1 and
FOXA2.
(B) Correlation between DEANR1 and FOXA2
expression levels in human ESCs (ES), neuro-
ectoderm (NE), embryoid body (EB), differentiated
mesendoderm cells (ME), DE, and sorted DE cells.
(C) Knockdown of DEANR1 in human ESCs re-
duces FOXA2 expression. Relative qRT-PCR re-
sults are presented, with the FOXA2 level in control
knockdown ESCs set as one. shRNA#2was used in
(C)–(F).
(D) FACS-sorted DEANR1-knockdown DE cells
exhibit decreased FOXA2 expression.
(E) Scatterplot of the fold change of differentially
expressed genes in DEANR1-knockdown and
FOXA2-knockdown cells.
(F) Venn diagram showing that the genes affected
by DEANR1 knockdown largely overlap with those
affected by FOXA2 knockdown. The common up-
regulated genes in both knockdowns include
pluripotent genes (NANOG and SOX2) and ecto-
derm (SOX3 and NES) and mesoderm (WNT5A and
THY1) marker genes. The common downregulated
genes include endoderm-specific genes (FOXA2,
GATA3, SOX17, and HNF1B).
(G) Representative FACS analysis results from
control, DEANR1-knockdown, and DEANR1-
knockdown rescue cells. The mean values are
shown and error bars represent the SD from the
mean (n = 3).
(H) Quantification of DE differentiation efficiency
in control, DEANR1-knockdown, and DEANR1-
knockdown rescue cells from three independent
experiments.
See also Figure S3 and Table S4.2012; Xie et al., 2013a, 2013b), and examined the correlation
between the expression levels of DEANR1 and transcription
factors important for endoderm differentiation, such as MIXL1,
SOX17, FOXA2, GSC, EOMES, and GATA6. We found that
only expression of FOXA2 was significantly correlated with
that of DEANR1 (Figure S3). Interestingly, FOXA2 is also physi-Cell Reports 11, 137cally close to DEANR1 in its genomic
location (Figure 5A). Given that previous
studies have demonstrated that lncRNAs
can function in cis to regulate expression
of adjacent protein-coding genes (Ørom
et al., 2010), we examined the possibility
that DEANR1 may facilitate DE differenti-
ation by regulating FOXA2 expression.
Consistent with this notion, we found
that the expression level of DEANR1
was highly correlated with the FOXA2
level in different cell types (Figures 5B
and S3). In addition, knockdown of
DEANR1 in human ESCs resulted in a
dramatic decrease of FOXA2 expression
(Figure 5C). A similar effect was alsoobserved in sorted CD184/CD117 double-positive endoderm
cells derived from DEANR1-knockdown cells (Figure 5D). A
gene-expression analysis in both undifferentiated ESCs (to
exclude the differentiation effect) and purified endoderm cells
(to bypass the endoderm differentiation defect) supported the
notion that DEANR1 regulates FOXA2 expression.–148, April 7, 2015 ª2015 The Authors 143
To determine whether FOXA2 is a major functional target of
DEANR1 in regulating DE differentiation, we first determined
the transcriptome changes in DEANR1-knockdown cells and
FOXA2-knockdown cells (80% knockdown efficiency; detailed
information is provided in Table S3). Analysis of the RNA-seq
data indicated that the changes induced by DEANR1 knock-
down and FOXA2 knockdown are highly correlated (Figure 5E).
Moreover, the genes affected by DEANR1 knockdown signifi-
cantly overlap with those affected by FOXA2 knockdown (Fig-
ure 5F). The common upregulated genes in both knockdowns
compared with control cells included pluripotent genes, ecto-
derm and mesoderm markers, and common downregulated
genes included endoderm markers. These results suggest that
either DEANR1 knockdown or FOXA2 knockdown results in
endoderm differentiation defects.
To further define the relationship between DEANR1 and
FOXA2, we attempted to rescue the DE differentiation defect
of DEANR1 knockdown by expressing exogenous FOXA2. To
this end, we infected DEANR1-knockdown human ESCs with vi-
ruses expressing FOXA2, followed by DE differentiation. A FACS
analysis demonstrated that the endoderm differentiation defect
caused by DEANR1 knockdown is successfully rescued by
expression of FOXA2 (Figures 5G and 5H), indicating that
FOXA2 is a major target that mediates the function of DEANR1
in endoderm differentiation.
DEANR1 Contributes to FOXA2 Transcription by
Facilitating SMAD2/3 Recruitment
We next attempted to address how DEANR1 contributes to
FOXA2 transcription. First, we examined the localization of the
DEANR1 RNA transcript. RNA fluorescent in situ hybridization
(FISH) demonstrated that DEANR1 is expressed and localized
only to FOXA2-positive nuclei (Figure 6A). We noticed that
DEANR1 localized to a limited number of nuclear foci (two spots
in most cases), which suggests thatDEANR1 has limited targets.
We also checked the genomic location of theDEANR1 transcript
by RNA-DNA dual FISH, and the results showed that the
DEANR1 transcript is located in the FOXA2 gene locus (Fig-
ure 6B). Taken together, these data suggest that DEANR1 likely
contributes to FOXA2 transcription in cis.
Previous studies demonstrated that FOXA2 expression could
be activated by several transcriptional factors, including SOX17
(Sinner et al., 2004), EOMES (Teo et al., 2011), and SMAD2/3
(Kim et al., 2011), during endoderm differentiation. Therefore,
we asked whether any of these transcription factors can asso-
ciate with DEANR1. Immunoprecipitation followed by qRT-
PCR analysis demonstrated that only the SMAD2/3 antibody
significantly enriched DEANR1 (Figure 6C). The enrichment of
DEANR1 by the SMAD2/3 antibody is specific, as the antibody
did not enrich for either the U1 small nuclear RNA (snRNA) or
another lncRNA, MALAT1 (Figure 6C). These data suggest that
DEANR1 may contribute to FOXA2 activation by associating
with SMAD2/3.
To examine whether binding of SMAD2/3 to the FOXA2 pro-
moter requires DEANR1, we first mapped the location of
SMAD2/3 on the FOXA2 gene locus. Chromatin immunoprecip-
itation (ChIP) assays demonstrated that SMAD2/3 binds to the
promoter of FOXA2, but is absent from the upstream proximal144 Cell Reports 11, 137–148, April 7, 2015 ª2015 The Authorsregion (Figure 6D). Importantly, knockdown of DEANR1 reduced
the binding of SMAD2/3 to the FOXA2 promoter region, but had
no significant effect on the binding of SMAD2/3 to another
SMAD2/3 target, EOMES (Figure 6E). These results suggest
thatDEANR1 associates with SMAD2/3 and facilitates its recruit-
ment to the FOXA2 promoter to activate FOXA2 expression.
DISCUSSION
In this study, we performed a comprehensive transcriptome
analysis of human endoderm and pancreatic lineage using highly
purified samples (Figure 1).We identified hundreds of stage-spe-
cific lncRNAs and characterized the function of DEANR1 in
endoderm differentiation. Our data suggest that DEANR1 plays
an important role in regulating endoderm differentiation. The
fact that overexpression of FOXA2 can largely rescue the endo-
derm differentiation defect caused by DEANR1 depletion sug-
gests that FOXA2 is a major functional target of DEANR1.
Furthermore, our data support the notion thatDEANR1 regulates
FOXA2 transcription in cis. DEANR1 associates with SMAD2/3
and facilitates its binding to the FOXA2 gene promoter to acti-
vate FOXA2 expression (Figure 6F), which in turn promotes
endoderm differentiation.
Our comprehensive transcriptome analysis of pancreatic
beta-cell lineage specification provides insight into the trans-
criptional dynamics underlying cell-fate conversion. First, we
observed a decrease in the number of actively transcribed genes
during differentiation, particularly in the terminally differentiated
islet cell types (Figure S1C), similar to what was observed in a
previous study regarding neural differentiation (Wu et al.,
2010). Together, the two studies suggest that restriction in
gene expression might be a common phenomenon during cell-
fate specialization. How to silence undesired gene expression
during differentiation should be an important question for future
investigations. Indeed, two recent studies that profiled the tran-
scriptome and histone K4me3 and K27me3 using human ESC-
derived pancreatic intermediate (Xie et al., 2013a) and primary
islet cell types (Bramswig et al., 2013) revealed that silencing
of transitory genes during lineage progression is associated
with reinstatement of Polycomb-dependent repression. Further-
more, DNA methylation-mediated transcription repression has
been reported to be essential for maintaining pancreatic beta
cell identity (Dhawan et al., 2011). Thus, it is likely that both
DNA methylation and H3K27 methylation play an important
role in silencing undesired gene expression to achieve cell line-
age restriction.
lncRNAs have been reported to participate in diverse biolog-
ical processes, including ESC maintenance, neural cell differen-
tiation, muscle differentiation, and hematopoiesis (Hu et al.,
2012), as well as cardiac development (Grote et al., 2013; Klat-
tenhoff et al., 2013) and epidermal differentiation (Kretz et al.,
2013). Although a recent study reported the expression of thou-
sands of lncRNAs during endodermal differentiation (Sigova
et al., 2013), no specific function has been assigned to any of
these lncRNAs during endoderm differentiation. Future charac-
terization of the other endoderm-specific and pancreatic-line-
age-specific lncRNAs identified in our study may reveal addi-
tional lncRNAs that are important for endoderm and pancreatic
Figure 6. DEANR1 Associates with SMAD2/
3 and Helps to Target It to the FOXA2 Pro-
moter
(A) RNA-FISH demonstrates nuclear localization of
DEANR1 only in FOXA2-positive DE cells. Scale
bar represents 5 mm.
(B) Dual RNA-DNA-FISH demonstrates that
DEANR1 transcripts (green signal) are localized to
the FOXA2 gene locus (red signal).
(C) SMAD2/3 antibodies immunoprecipitate
DEANR1, but not U1 snRNA or lncRNA MALAT1.
(D) ChIP analysis demonstrates binding of SMAD2/
3 to the promoter region of the FOXA2 gene locus.
IgG serves as a control. The genomic location of
the analyzed regions is indicated in the diagram at
the top of the panel.
(E) Knockdown of DEANR1 reduces binding of
SMAD2/3 to the FOXA2 promoter, but not to
another SMAD2/3 target, EOMES. The mean
values are shown and error bars represent the SD
from themean (n = 3). Significance was determined
by two-tailed Student’s t test, and the p value is
presented.
(F) Hypothetical model illustrating how DEANR1
might regulate FOXA2 transcription in cis. The
genomic locations of DEANR1 and FOXA2 genes
are shown on the top line and the arrows indicate
the transcription direction. Upon DEANR1 activa-
tion, chromatin looping brings the DEANR1 locus
spatially close to the FOXA2 promoter region (20
kb between the DEANR1 gene body and the
FOXA2 promoter). The transcribed DEANR1 in-
teracts with SMAD2/3 protein and brings SMAD2/3
to the FOXA2 promoter by forming DNA-RNA hy-
dride for specific targeting of SMAD2/3 to the
FOXA2 promoter. Together with other transcription
machinery, binding of SMAD2/3 to the FOXA2
promoter initiates transcription.
See also Table S4.lineage specification. In addition, lncRNAs have been shown
to act both in cis and in trans (Rinn and Chang, 2012; Ulitsky
and Bartel, 2013). The observation that more than 60% of
endoderm-expressed lncRNAs exhibit coordinated expression
changes with their adjacent protein-coding genes (Sigova
et al., 2013) suggests that cis regulation or local interactionCell Reports 11, 137between lncRNAs and their neighboring
protein-coding genes may be a common
feature of endoderm differentiation. The
demonstration that DEANR1 contributes
to DE differentiation by regulating its
neighboring gene, FOXA2, is consistent
with this notion.
Nodal/activin signaling activates the
SMAD2/3 pathway and promotes endo-
derm differentiation (Zorn and Wells,
2009). Secreted Nodal binds and acti-
vates ALK4/7, which in turn activates
cytosolic SMAD2 and/or SMAD3 by phos-
phorylation. Phosphorylated SMAD2/3
then enters the nucleus to activate itsdownstream targets. While the mechanism of SMAD2/3 activa-
tion is conserved and well documented, the mechanisms by
which SMAD2/3 activate their downstream target genes ap-
pears to be cell-context dependent (Feng and Derynck, 2005;
Massague´ et al., 2005). Although the MH1 domain of SMAD3
is capable of binding to DNA through Smad-binding elements–148, April 7, 2015 ª2015 The Authors 145
with weak affinity, native SMAD target promoters seldom con-
tain such Smad-binding elements, and thus many partners,
including DNA-binding proteins, have been reported to form
complexes with SMAD2/3 to activate SMAD2/3 target gene
expression (Feng and Derynck, 2005; Massague´ et al., 2005).
In our study, we demonstrated that the association of DEANR1
with SMAD2/3 can facilitate SMAD2/3 binding to the FOXA2 pro-
moter. Based on the data we have obtained so far, we propose a
hypothetical model that may explain how DEANR1 contributes
to FOXA2 activation and endoderm differentiation (Figure 6F).
It is possible that activation of DEANR1 by an endoderm differ-
entiation signal causes chromatin looping to make the DEANR1
locus spatially close to the FOXA2 promoter. The DEANR1 tran-
scripts can help bring SMAD2/3 to the FOXA2 promoter through
a specific interaction with SMAD2/3 and at the same time base
pair with a certain region of DNA that encodes DEANR1.
Together with the recruitment of other transcription machinery,
transcription of FOXA2 can be initiated. We cannot rule out the
possibility that other proteins are also required for the binding
of DEANR1 to SMAD2/3, since no report has suggested that
Smad2 is associated with an intrinsic RNA-binding property,
and some RNA-binding proteins have been shown to be able
to physically interact with Smad2, Smad3, and Smad4 (Sun
et al., 2006). However, adenomatous polyposis coli (APC), a
well-studied protein that is involved in the microtubule and
WNT signaling pathway, was recently reported to be an RNA-
binding protein (Preitner et al., 2014). Nevertheless, RNA-medi-
ated SMAD2/3 targeting represents an alternative mechanism
by which SMAD2/3 are recruited to their targets.
EXPERIMENTAL PROCEDURES
Sample Preparation for RNA-Seq
The following antibodies (all purchased from BD Biosciences) were used to la-
bel different cell populations for flow cytometry on a FACSAria II with FACS-
Diva software (version 6.0; BD Biosciences) as described previously (Dorrell
et al., 2011): SSEA4+/CD184 for undifferentiated human ESCs; CD184+/
CD117+ for DE; CD24high/CD49fmed for PPs; HPi2+/HPa1 for beta cells;
and HPi2+/HPa1+ for alpha cells. DE cells and PPs were differentiated as pre-
viously described (Jiang et al., 2011) with minor modifications. Two individual
islet preparations were used to generate alpha1/beta1 and alpha2/beta2 sam-
ples for sequencing.
RNA Deep Sequencing and Data Analysis
Total RNA was purified from 1,000 sorted cells using a ZR RNA microprep
kit (Zymo Research). cDNA synthesis and amplification were performed
with the SMARTer ultra-low input RNA kit (Clontech). Amplified cDNA
(10–40 ng) was then fragmented by a Covaris S2 sonicator (Covaris) and
converted to sequencing libraries with barcode in an Illumina Hiseq 2000
instrument (pair-end 100 bp). All obtained reads from each sample were
mapped against the human genome (hg19 build) with Bowtie/Tophat
v2.0.2, which allows mapping across splice sites by reads segmentation
(Trapnell et al., 2012). The uniquely mapped reads were subsequently
assembled into transcripts guided by reference annotation (Gencode v14
and RefSeq gene models) (Harrow et al., 2012; Pruitt et al., 2012) with Cuf-
flinks v2.0.2 (Trapnell et al., 2012). The expression level of each gene was
quantified with normalized FPKM (fragments per kilobase of exon per
million mapped fragments). Functional annotation of significantly different
transcripts and enrichment analysis were performed with DAVID (Huang
et al., 2009).
To quantify the stage specificity of genes and lncRNAs, the expression
levels of the samples in a certain stage versus the other samples in human146 Cell Reports 11, 137–148, April 7, 2015 ª2015 The Authorsendoderm and pancreatic lineage were compared. The islet-specificity score
of each transcript was defined as follows:
score=meanA ðmeanOther + 2  sdOtherÞ;
where meanA is the mean expression of the samples in certain stage, and
meanOther and sdOther are the mean and SD of the expression levels in the
other samples, respectively. Therefore, a positive score indicated that the
gene or lncRNAs was expressed in a certain stage at a considerably higher
level than in the rest of the stages. A gene or lncRNA with a score of >0.5
was considered as specifically expressed in a certain stage.
Genetic Manipulation
The human ESC line HUES8, cultured without feeder, was used to generate
stable knockdown cell lines. A lentiviral vector system containing the murine
U6-shRNA cassette and a puromycin selection marker was used to achieve
high transfection efficiency. We used two efficient shRNA targeting sites
against DEANR1 and one against FOXA2, as follows: DEANR1-shRNA1,
GAAAGCTGTAGCCATTCAA (position: 761–779 nt); DEANR1-shRNA2,
GCAATTAATTCAGGACACT (position: 2,979–2,997 nt); and FOXA2-shRNA,
GCAAGGGAGAAGAAATCCATA.
FISH
Sequential protein staining and RNA detection were performed as previously
described (Namekawa and Lee, 2011; Takizawa et al., 2008). In brief, RNA-
FISH was performed by using a nick-translated probe (Roche) followed by a
tyramide signal amplification kit (Life Technologies). After RNA-FISH, the cells
were treated by RNase A and denatured. Nick-translated BAC containing
FOXA2 (RP11-842A16) was labeled as a DNA probe.
RNA-Binding Protein Immunoprecipitation and ChIP
An RNA-binding protein immunoprecipitation (RIP) assay was performed
using the Magna RIP kit (Millipore) according to the manufacturer’s in-
struction. Cell lysates from 10 million cells and 2–5 mg of control IgG
or antibody against SOX17 (R&D, AF1924), EOMES (Abcam, ab23345),
or SMAD2/3 (R&D, AF3797) were used. We validated the RIP assay us-
ing the SNRNP70 antibody, which can bind to U1 snRNA. A ChIP assay
was performed using magnetic beads. Equal amounts of chromatin from
each sample and 1 mg of control IgG or antibody against SMAD2/3 were
used.
ACCESSION NUMBERS
The data reported in this paper have been deposited to the NCBI GEO and are
available under accession number GSE44875.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.03.008.
AUTHOR CONTRIBUTIONS
W.J. and Y.Z. conceived the project, designed the experiments, and wrote the
manuscript. W.J. performed the experiments. Y.L. performed the bioinformat-
ics analysis. R.L. prepared the low-input library and helped with the bioinfor-
matics analysis. K.Z. assisted in analysis and data interpretation.
ACKNOWLEDGMENTS
We thank Dr. Philip Streeter (Oregon Stem Cell Center) for providing the anti-
bodies against HPi2 andHPa1.We also thank Drs. Donghui Zhang and Shinpei
Yamaguchi for their help inmaking Figure 6F, Drs. Azusa Inoue and ShogoMa-
toba for advice on RNA-FISH, andDr. LuisM. Tuesta for a critical reading of the
manuscript. This work was supported by NIH grant U01-DK089565 (Y.Z.). W.J.
is supported by a Juvenile Diabetes Research Foundation postdoctoral
fellowship (3-2012-293). Y.Z. is an Investigator of the Howard Hughes Medical
Institute.
Received: January 21, 2015
Revised: February 12, 2015
Accepted: February 27, 2015
Published: April 2, 2015REFERENCES
Bramswig, N.C., Everett, L.J., Schug, J., Dorrell, C., Liu, C., Luo, Y., Streeter,
P.R., Naji, A., Grompe, M., and Kaestner, K.H. (2013). Epigenomic plasticity
enables human pancreatic a to b cell reprogramming. J. Clin. Invest. 123,
1275–1284.
Cabili, M.N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A., and
Rinn, J.L. (2011). Integrative annotation of human large intergenic noncoding
RNAs reveals global properties and specific subclasses. Genes Dev. 25,
1915–1927.
Carninci, P., Kasukawa, T., Katayama, S., Gough, J., Frith, M.C., Maeda, N.,
Oyama, R., Ravasi, T., Lenhard, B., Wells, C., et al.; FANTOM Consortium;
RIKEN Genome Exploration Research Group and Genome Science Group
(Genome Network Project Core Group) (2005). The transcriptional landscape
of the mammalian genome. Science 309, 1559–1563.
Cheng, X., Ying, L., Lu, L., Galva˜o, A.M., Mills, J.A., Lin, H.C., Kotton, D.N.,
Shen, S.S., Nostro, M.C., Choi, J.K., et al. (2012). Self-renewing endodermal
progenitor lines generated from human pluripotent stem cells. Cell Stem Cell
10, 371–384.
D’Amour, K.A., Bang, A.G., Eliazer, S., Kelly, O.G., Agulnick, A.D., Smart, N.G.,
Moorman, M.A., Kroon, E., Carpenter, M.K., and Baetge, E.E. (2006). Produc-
tion of pancreatic hormone-expressing endocrine cells from human embryonic
stem cells. Nat. Biotechnol. 24, 1392–1401.
Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guer-
nec, G., Martin, D., Merkel, A., Knowles, D.G., et al. (2012). The GENCODE v7
catalog of human long noncoding RNAs: analysis of their gene structure, evo-
lution, and expression. Genome Res. 22, 1775–1789.
Dhawan, S., Georgia, S., Tschen, S.I., Fan, G., and Bhushan, A. (2011).
Pancreatic b cell identity is maintained by DNA methylation-mediated repres-
sion of Arx. Dev. Cell 20, 419–429.
Djebali, S., Davis, C.A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A.,
Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012). Landscape of
transcription in human cells. Nature 489, 101–108.
Dorrell, C., Abraham, S.L., Lanxon-Cookson, K.M., Canaday, P.S., Streeter,
P.R., and Grompe, M. (2008). Isolation of major pancreatic cell types and
long-term culture-initiating cells using novel human surface markers. Stem
Cell Res. (Amst.) 1, 183–194.
Dorrell, C., Schug, J., Lin, C.F., Canaday, P.S., Fox, A.J., Smirnova, O., Bon-
nah, R., Streeter, P.R., Stoeckert, C.J., Jr., Kaestner, K.H., and Grompe, M.
(2011). Transcriptomes of the major human pancreatic cell types. Diabetologia
54, 2832–2844.
Feng, X.H., and Derynck, R. (2005). Specificity and versatility in tgf-beta
signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659–693.
Grote, P., Wittler, L., Hendrix, D., Koch, F., Wa¨hrisch, S., Beisaw, A., Macura,
K., Bla¨ss, G., Kellis, M., Werber, M., and Herrmann, B.G. (2013). The tissue-
specific lncRNA Fendrr is an essential regulator of heart and body wall devel-
opment in the mouse. Dev. Cell 24, 206–214.
Harrow, J., Frankish, A., Gonzalez, J.M., Tapanari, E., Diekhans, M., Kokocin-
ski, F., Aken, B.L., Barrell, D., Zadissa, A., Searle, S., et al. (2012). GENCODE:
the reference human genome annotation for The ENCODE Project. Genome
Res. 22, 1760–1774.
Hu, W., Alvarez-Dominguez, J.R., and Lodish, H.F. (2012). Regulation of
mammalian cell differentiation by long non-coding RNAs. EMBO Rep. 13,
971–983.Huang, W., Sherman, B.T., and Lempicki, R.A. (2009). Systematic and integra-
tive analysis of large gene lists using DAVID bioinformatics resources. Nat.
Protoc. 4, 44–57.
Jiang, W., Shi, Y., Zhao, D., Chen, S., Yong, J., Zhang, J., Qing, T., Sun, X.,
Zhang, P., Ding, M., et al. (2007). In vitro derivation of functional insulin-pro-
ducing cells from human embryonic stem cells. Cell Res. 17, 333–344.
Jiang, W., Sui, X., Zhang, D., Liu, M., Ding, M., Shi, Y., and Deng, H. (2011).
CD24: a novel surface marker for PDX1-positive pancreatic progenitors
derived from human embryonic stem cells. Stem Cells 29, 609–617.
Jiang, W., Wang, J., and Zhang, Y. (2013a). Histone H3K27me3 demethylases
KDM6A and KDM6Bmodulate definitive endoderm differentiation from human
ESCs by regulating WNT signaling pathway. Cell Res. 23, 122–130.
Jiang, W., Zhang, D., Bursac, N., and Zhang, Y. (2013b). WNT3 is a biomarker
capable of predicting the definitive endoderm differentiation potential of
hESCs. Stem Cell Reports 1, 46–52.
Katayama, S., Tomaru, Y., Kasukawa, T., Waki, K., Nakanishi, M., Nakamura,
M., Nishida, H., Yap, C.C., Suzuki, M., Kawai, J., et al.; RIKEN Genome Explo-
ration Research Group; Genome Science Group (Genome Network Project
Core Group); FANTOM Consortium (2005). Antisense transcription in the
mammalian transcriptome. Science 309, 1564–1566.
Kim, S.W., Yoon, S.J., Chuong, E., Oyolu, C., Wills, A.E., Gupta, R., and Baker,
J. (2011). Chromatin and transcriptional signatures for Nodal signaling during
endoderm formation in hESCs. Dev. Biol. 357, 492–504.
Klattenhoff, C.A., Scheuermann, J.C., Surface, L.E., Bradley, R.K., Fields, P.A.,
Steinhauser, M.L., Ding, H., Butty, V.L., Torrey, L., Haas, S., et al. (2013).
Braveheart, a long noncoding RNA required for cardiovascular lineage
commitment. Cell 152, 570–583.
Kretz, M., Siprashvili, Z., Chu, C.,Webster, D.E., Zehnder, A., Qu, K., Lee, C.S.,
Flockhart, R.J., Groff, A.F., Chow, J., et al. (2013). Control of somatic tissue dif-
ferentiation by the long non-coding RNA TINCR. Nature 493, 231–235.
Kroon, E., Martinson, L.A., Kadoya, K., Bang, A.G., Kelly, O.G., Eliazer, S.,
Young, H., Richardson, M., Smart, N.G., Cunningham, J., et al. (2008). Pancre-
atic endoderm derived from human embryonic stem cells generates glucose-
responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443–452.
Massague´, J., Seoane, J., and Wotton, D. (2005). Smad transcription factors.
Genes Dev. 19, 2783–2810.
McKnight, K.D., Wang, P., and Kim, S.K. (2010). Deconstructing pancreas
development to reconstruct human islets from pluripotent stem cells. Cell
Stem Cell 6, 300–308.
Mora´n, I., Akerman, I., van de Bunt, M., Xie, R., Benazra, M., Nammo, T.,
Arnes, L., Nakic, N., Garcı´a-Hurtado, J., Rodrı´guez-Seguı´, S., et al. (2012). Hu-
man b cell transcriptome analysis uncovers lncRNAs that are tissue-specific,
dynamically regulated, and abnormally expressed in type 2 diabetes. Cell
Metab. 16, 435–448.
Namekawa, S.H., and Lee, J.T. (2011). Detection of nascent RNA, single-copy
DNA and protein localization by immunoFISH in mouse germ cells and preim-
plantation embryos. Nat. Protoc. 6, 270–284.
Nostro, M.C., Sarangi, F., Ogawa, S., Holtzinger, A., Corneo, B., Li, X., Micallef,
S.J., Park, I.H., Basford, C., Wheeler, M.B., et al. (2011). Stage-specific
signaling through TGFb family members and WNT regulates patterning and
pancreatic specification of human pluripotent stem cells. Development 138,
861–871.
Ørom, U.A., Derrien, T., Beringer, M., Gumireddy, K., Gardini, A., Bussotti, G.,
Lai, F., Zytnicki, M., Notredame, C., Huang, Q., et al. (2010). Long noncoding
RNAs with enhancer-like function in human cells. Cell 143, 46–58.
Pagliuca, F.W., Millman, J.R., Gu¨rtler, M., Segel, M., Van Dervort, A., Ryu, J.H.,
Peterson, Q.P., Greiner, D., and Melton, D.A. (2014). Generation of functional
human pancreatic b cells in vitro. Cell 159, 428–439.
Paige, S.L., Thomas, S., Stoick-Cooper, C.L., Wang, H., Maves, L., Sand-
strom, R., Pabon, L., Reinecke, H., Pratt, G., Keller, G., et al. (2012). A temporal
chromatin signature in human embryonic stem cells identifies regulators of
cardiac development. Cell 151, 221–232.Cell Reports 11, 137–148, April 7, 2015 ª2015 The Authors 147
Preitner, N., Quan, J., Nowakowski, D.W., Hancock, M.L., Shi, J., Tcherkezian,
J., Young-Pearse, T.L., and Flanagan, J.G. (2014). APC is an RNA-binding pro-
tein, and its interactome provides a link to neural development and microtu-
bule assembly. Cell 158, 368–382.
Pruitt, K.D., Tatusova, T., Brown, G.R., and Maglott, D.R. (2012). NCBI Refer-
ence Sequences (RefSeq): current status, new features and genome annota-
tion policy. Nucleic Acids Res. 40, D130–D135.
Rezania, A., Bruin, J.E., Arora, P., Rubin, A., Batushansky, I., Asadi, A.,
O’Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., et al. (2014). Reversal
of diabetes with insulin-producing cells derived in vitro from human pluripotent
stem cells. Nat. Biotechnol. 32, 1121–1133.
Rinn, J.L., and Chang, H.Y. (2012). Genome regulation by long noncoding
RNAs. Annu. Rev. Biochem. 81, 145–166.
Sauvageau, M., Goff, L.A., Lodato, S., Bonev, B., Groff, A.F., Gerhardinger, C.,
Sanchez-Gomez, D.B., Hacisuleyman, E., Li, E., Spence, M., et al. (2013). Mul-
tiple knockout mouse models reveal lincRNAs are required for life and brain
development. eLife 2, e01749.
Sigova, A.A., Mullen, A.C., Molinie, B., Gupta, S., Orlando, D.A., Guenther,
M.G., Almada, A.E., Lin, C., Sharp, P.A., Giallourakis, C.C., and Young, R.A.
(2013). Divergent transcription of long noncoding RNA/mRNA gene pairs in
embryonic stem cells. Proc. Natl. Acad. Sci. USA 110, 2876–2881.
Sinner, D., Rankin, S., Lee, M., and Zorn, A.M. (2004). Sox17 and beta-catenin
cooperate to regulate the transcription of endodermal genes. Development
131, 3069–3080.
Sun, Y., Ding, L., Zhang, H., Han, J., Yang, X., Yan, J., Zhu, Y., Li, J., Song, H.,
and Ye, Q. (2006). Potentiation of Smad-mediated transcriptional activation by
the RNA-binding protein RBPMS. Nucleic Acids Res. 34, 6314–6326.
Takizawa, T., Gudla, P.R., Guo, L., Lockett, S., and Misteli, T. (2008). Allele-
specific nuclear positioning of the monoallelically expressed astrocyte marker
GFAP. Genes Dev. 22, 489–498.
Teo, A.K., Arnold, S.J., Trotter, M.W., Brown, S., Ang, L.T., Chng, Z., Robert-
son, E.J., Dunn, N.R., and Vallier, L. (2011). Pluripotency factors regulate
definitive endoderm specification through eomesodermin. Genes Dev. 25,
238–250.148 Cell Reports 11, 137–148, April 7, 2015 ª2015 The AuthorsTrapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel,
H., Salzberg, S.L., Rinn, J.L., and Pachter, L. (2012). Differential gene and tran-
script expression analysis of RNA-seq experiments with TopHat and Cufflinks.
Nat. Protoc. 7, 562–578.
Ulitsky, I., and Bartel, D.P. (2013). lincRNAs: genomics, evolution, and mech-
anisms. Cell 154, 26–46.
Wang, K.C., and Chang, H.Y. (2011). Molecular mechanisms of long noncod-
ing RNAs. Mol. Cell 43, 904–914.
Wang, P., Xue, Y., Han, Y., Lin, L., Wu, C., Xu, S., Jiang, Z., Xu, J., Liu, Q., and
Cao, X. (2014). The STAT3-binding long noncoding RNA lnc-DC controls hu-
man dendritic cell differentiation. Science 344, 310–313.
Wu, J.Q., Habegger, L., Noisa, P., Szekely, A., Qiu, C., Hutchison, S., Raha, D.,
Egholm, M., Lin, H., Weissman, S., et al. (2010). Dynamic transcriptomes dur-
ing neural differentiation of human embryonic stem cells revealed by short,
long, and paired-end sequencing. Proc. Natl. Acad. Sci. USA 107, 5254–5259.
Xie, R., Everett, L.J., Lim, H.W., Patel, N.A., Schug, J., Kroon, E., Kelly, O.G.,
Wang, A., D’Amour, K.A., Robins, A.J., et al. (2013a). Dynamic chromatin re-
modeling mediated by polycomb proteins orchestrates pancreatic differentia-
tion of human embryonic stem cells. Cell Stem Cell 12, 224–237.
Xie, W., Schultz, M.D., Lister, R., Hou, Z., Rajagopal, N., Ray, P., Whitaker,
J.W., Tian, S., Hawkins, R.D., Leung, D., et al. (2013b). Epigenomic analysis
of multilineage differentiation of human embryonic stem cells. Cell 153,
1134–1148.
Yamaguchi, S., Hong, K., Liu, R., Shen, L., Inoue, A., Diep, D., Zhang, K., and
Zhang, Y. (2012). Tet1 controls meiosis by regulating meiotic gene expression.
Nature 492, 443–447.
Zhang, D., Jiang, W., Liu, M., Sui, X., Yin, X., Chen, S., Shi, Y., and Deng, H.
(2009). Highly efficient differentiation of human ES cells and iPS cells into
mature pancreatic insulin-producing cells. Cell Res. 19, 429–438.
Zorn, A.M., andWells, J.M. (2009). Vertebrate endoderm development and or-
gan formation. Annu. Rev. Cell Dev. Biol. 25, 221–251.
